亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Shining a LIGHT on myeloid cell targeted immunotherapy

免疫疗法 髓系细胞 医学 髓样 癌症研究 免疫学 免疫系统
作者
Casey W. Shuptrine,Vincent M. Perez,Sara R. Selitsky,Taylor H. Schreiber,George Fromm
出处
期刊:European Journal of Cancer [Elsevier]
卷期号:187: 147-160 被引量:6
标识
DOI:10.1016/j.ejca.2023.03.040
摘要

Despite over a decade of clinical trials combining inhibition of emerging checkpoints with a PD-1/L1 inhibitor backbone, meaningful survival benefits have not been shown in PD-1/L1 inhibitor resistant or refractory solid tumours, particularly tumours dominated by a myelosuppressive microenvironment. Achieving durable anti-tumour immunity will therefore likely require combination of adaptive and innate immune stimulation, myeloid repolarisation, enhanced APC activation and antigen processing/presentation, lifting of the CD47/SIRPα (Cluster of Differentiation 47/signal regulatory protein alpha) 'do not eat me' signal, provision of an apoptotic 'pro-eat me' or 'find me' signal, and blockade of immune checkpoints. The importance of effectively targeting mLILRB2 and SIRPAyeloid cells to achieve improved response rates has recently been emphasised, given myeloid cells are abundant in the tumour microenvironment of most solid tumours. TNFSF14, or LIGHT, is a tumour necrosis superfamily ligand with a broad range of adaptive and innate immune activities, including (1) myeloid cell activation through Lymphotoxin Beta Receptor (LTβR), (2) T/NK (T cell and natural killer cell) induced anti-tumour immune activity through Herpes virus entry mediator (HVEM), (3) potentiation of proinflammatory cytokine/chemokine secretion through LTβR on tumour stromal cells, (4) direct induction of tumour cell apoptosis in vitro, and (5) the reorganisation of lymphatic tissue architecture, including within the tumour microenvironment (TME), by promoting high endothelial venule (HEV) formation and induction of tertiary lymphoid structures. LTBR (Lymphotoxin beta receptor) and HVEM rank highly amongst a range of costimulatory receptors in solid tumours, which raises interest in considering how LIGHT-mediated costimulation may be distinct from a growing list of immunotherapy targets which have failed to provide survival benefit as monotherapy or in combination with PD-1 inhibitors, particularly in the checkpoint acquired resistant setting.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
29秒前
47秒前
1分钟前
啊强完成签到 ,获得积分10
1分钟前
无限毛豆发布了新的文献求助10
1分钟前
xiaolang2004完成签到,获得积分10
1分钟前
上官若男应助无限毛豆采纳,获得10
1分钟前
莉莉安完成签到 ,获得积分10
1分钟前
2分钟前
knoren发布了新的文献求助10
2分钟前
DeaR完成签到 ,获得积分10
2分钟前
knoren完成签到,获得积分10
2分钟前
3分钟前
止戈发布了新的文献求助10
3分钟前
3分钟前
小巫发布了新的文献求助10
4分钟前
科研菜狗完成签到 ,获得积分10
4分钟前
小马甲应助lbjcp3采纳,获得10
4分钟前
小巫完成签到,获得积分10
4分钟前
4分钟前
lbjcp3发布了新的文献求助10
4分钟前
脑洞疼应助zhangxr采纳,获得10
5分钟前
丘比特应助科研通管家采纳,获得10
5分钟前
乐乐应助科研通管家采纳,获得10
5分钟前
高高代珊完成签到 ,获得积分10
5分钟前
安输发布了新的文献求助10
5分钟前
hyl1115发布了新的文献求助30
6分钟前
安输完成签到,获得积分10
6分钟前
6分钟前
CHENCHEN完成签到,获得积分10
6分钟前
6分钟前
科研通AI2S应助Vivalavida采纳,获得10
6分钟前
6分钟前
松子发布了新的文献求助20
6分钟前
6分钟前
Rn完成签到 ,获得积分10
6分钟前
佛系研究僧完成签到,获得积分10
7分钟前
科研通AI2S应助松子采纳,获得10
7分钟前
7分钟前
汉堡包应助lalalatiancai采纳,获得10
7分钟前
高分求助中
The Oxford Handbook of Social Cognition (Second Edition, 2024) 1050
Kinetics of the Esterification Between 2-[(4-hydroxybutoxy)carbonyl] Benzoic Acid with 1,4-Butanediol: Tetrabutyl Orthotitanate as Catalyst 1000
The Young builders of New china : the visit of the delegation of the WFDY to the Chinese People's Republic 1000
Rechtsphilosophie 1000
Handbook of Qualitative Cross-Cultural Research Methods 600
Chen Hansheng: China’s Last Romantic Revolutionary 500
Mantiden: Faszinierende Lauerjäger Faszinierende Lauerjäger 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3139548
求助须知:如何正确求助?哪些是违规求助? 2790430
关于积分的说明 7795269
捐赠科研通 2446905
什么是DOI,文献DOI怎么找? 1301487
科研通“疑难数据库(出版商)”最低求助积分说明 626238
版权声明 601146